Skip to content
ClinCalc Pro
Menu
Analgesic + Antiemetic (Migraine Treatment)

Aspirin with Metoclopramide

Brand names: MigraMax

A fixed combination of aspirin (an analgesic/NSAID) with metoclopramide (an antiemetic and prokinetic) used for the acute treatment of migraine attacks.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

Aspirin relieves migraine pain by inhibiting cyclo-oxygenase and prostaglandin synthesis, while metoclopramide controls nausea and, by promoting gastric emptying, enhances aspirin absorption during an attack.

Prescribing in practice

  • Metoclopramide can cause acute dystonic and other extrapyramidal reactions, particularly in younger patients, so use is restricted to short-term acute treatment; aspirin adds the usual gastrointestinal bleeding and Reye's-syndrome cautions.
  • Avoid the aspirin component in active peptic ulcer disease, bleeding disorders and aspirin hypersensitivity, and the combination in children and young people.
  • It should be used only for acute attacks, not for frequent or prophylactic use, to avoid medication-overuse headache and cumulative metoclopramide exposure.

Monitoring

No routine monitoring is needed for occasional use; watch for extrapyramidal reactions and gastrointestinal bleeding.

Counselling the patient

  • Use only for acute migraine attacks and avoid frequent use to prevent rebound headache.
  • Seek urgent help if you develop abnormal muscle spasms, especially of the face, neck or eyes.
  • Take with food and report any black stools or stomach pain.

Evidence & guidelines

Aspirin combined with an antiemetic is recommended by NICE as an option for the acute treatment of migraine.

Reference: NICE NG150 (Headaches: diagnosis and management, 2021); British Association for the Study of Headache (BASH) Guidelines; Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.